Nyxoah NYXH
NASDAQ NYXH
$1.40 -0.08 (-5.41%)
At close: Sep 22, 2026 · 4:00 PM EDT

Nyxoah (NYXH) EBITDA Margin Growth (3y) (2024 - 2026)

Analysis

Nyxoah (NYXH) EBITDA Margin Growth (3y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 178.18 Bn 173.23 Bn 7.27 Bn -201.00
2 Intuitive Surgical 142.14 Bn 137.06 Bn 1.96 Bn 722.00
3 Medtronic 117.43 Bn 109.23 Bn 6.34 Bn 162.00
4 Stryker 105.15 Bn 101.68 Bn 4.50 Bn 586.00
5 Boston Scientific 63.37 Bn 63.08 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 50.93 Bn 46.79 Bn 1.35 Bn 887.00
7 Dexcom 33.65 Bn 31.71 Bn 830.00 Mn 963.00
8 Resmed 32.27 Bn 30.80 Bn 861.22 Mn 612.00
9 Alcon 31.62 Bn 30.17 Bn 1.68 Bn -1,075.00
10 Nyxoah 63.68 Mn -49.98 Mn 5.33 Mn 80,519.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80,519.00
Mar 31, 2026 -227,866.00
Dec 31, 2025 117,056.00
Sep 30, 2025 618,241.00
Jun 30, 2025 -75,062.00
Mar 31, 2025 83,512.00
Dec 31, 2024 386,048.00
Sep 30, 2024 529,670.00
Jun 30, 2024 192,347.00
Mar 31, 2024 -188,180.00
API Access

Nyxoah EBITDA Margin Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin-growth-3y&ticker=NYXH&period=max&api_key=YOUR_API_KEY